Prosecution Insights
Last updated: April 19, 2026

River Stone Biotech Aps

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18288012 Glycosylated Opioids CLARKE, TRENT R 1651 Non-Final OA Oct 23, 2023
17758660 Preparation of Buprenorphine MOORE, SUSANNA 1624 Final Rejection Jul 12, 2022
17768834 GENETICALLY MODIFIED HOST CELLS PRODUCING BENZYLISOQUINOLINE ALKALOIDS SAIDHA, TEKCHAND 1652 Final Rejection Apr 13, 2022

Managing River Stone Biotech Aps's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month